“First” Civilian Su-27 Flanker For Sale

Gemini Sparkle

Key Takeaways:

  • A newly restored, civilian-operated Sukhoi Su-27 Flanker, claimed to be the first licensed in the U.S. and one of only two privately owned globally, has completed its first flight and is now for sale.
  • The aircraft has undergone extensive restoration, featuring zero-time airframes and engines, full demilitarization, and re-instrumentation for IFR flight.
  • Pride Aircraft, the selling agent, is marketing this unique fighter as an "extraordinary high-performance aircraft" for serious buyers, with the price undisclosed.
See a mistake? Contact us.

The “first” civilian-operated, privately owned Sukhoi Su-27 Flanker in the world, according to the people who are trying to sell it, is fresh off its restoration, flew Dec. 10 at Rockford, Ill., and is now for sale. Pride Aircraft says the jet departed Runway 25 into a 15-knot headwind, after a 1,100-foot ground roll at Chicago Rockford International Airport. The jet flew locally for about 45 minutes in 7-degree air (14 Celsius) and performed multiple missed approaches before landing. According to the FAA’s online registry, the fighter is flying on a temporary certificate issued Dec. 2, 2009, that expires Jan. 1, 2010. According to Pride, the jet is the first ever to be “licensed” in the USA and one of a pair that represents “the first and only” two privately owned Flankers (both two-seat UB models) in the world.

The aircraft have been restored and relabeled (Russian placards don’t help English-reading pilots) and are fully IFR instrumented. Pride says the aircraft arrived in completely demilitarized condition and are now ready with “freshly-overhauled (zero-time)” airframes and zero-time engines. As a selling agent, Pride hasn’t listed a price, and is seeking to deter tire-kickers. But for those with the green, the company says it’s offering “by far the most extraordinary high-performance aircraft you can own.”

Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.